Stefan Daniluk

Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study

Sudha Visvanathan, Stefan Daniluk, Rafał Ptaszyński et al. · Annals of the Rheumatic Diseases · 2019 · 58 citations · Full text

Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study

Kim Papp, Mark Lebwohl, Diamant Thaçi et al. · BioDrugs · 2023 · 21 citations · Full text

The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland

J Badurski, John А. Kanis, Helena Johansson et al. · Polskie Archiwum Medycyny Wewnętrznej · 2011 · 14 citations